Fund HoldingsTYBOURNE CAPITAL MANAGEMENT (HK) LTD

Total Portfolio Value
$30.93M
Total Bought
$0
Total Sold
$11.90M
Net Transaction
-$11.90M
Filing Period:
Securities
SharesValue ($K)
Q2 2025
Q3 2025
Change
Q2 2025
Q3 2025
Weight (%)
Change
TAYSHA GENE THERAPIES INC (TSHA US)(TSHA)4,095,0003,700,000-395,0009,45912,09939.11%+2,640
FORTE BIOSCIENCES INC (FBRX US)(FBRX)786,647786,647010,17111,80038.15%+1,628
ALUMIS INC (ALMS US)1,399,2501,399,25004,1985,58318.05%+1,385
ZENTALIS PHARMACEUTICALS INC (ZNTL US)1,478,152961,486-516,6661,7151,4524.69%-263
MALIBU BOATS INC (MBUU US)66,7050-66,7052,0910-2,091
BICYCLE THERAPEUTICS LTD-ADR (BCYC US)993,7430-993,7436,9070-6,907
Page 1 of 1